Ethylmalonic acid

Ethylmalonic acid is a lipid of Fatty Acyls (FA) class. Ethylmalonic acid is associated with abnormalities such as Petechiae and Metabolic Diseases. The involved functions are known as Oxidation, Catabolic Process, Excretory function and Acidemia. Ethylmalonic acid often locates in Mitochondria. The associated genes with Ethylmalonic acid are N-caproylglycine and ETHE1 gene. The related lipids are Fatty Acids and sebacic acid.

Cross Reference

Introduction

To understand associated biological information of Ethylmalonic acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Ethylmalonic acid?

Ethylmalonic acid is suspected in Petechiae, Metabolic Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Ethylmalonic acid

MeSH term MeSH ID Detail
Multiple Acyl Coenzyme A Dehydrogenase Deficiency D054069 1 associated lipids
Mitochondrial Encephalomyopathies D017237 2 associated lipids
Muscle Hypotonia D009123 5 associated lipids
Brain Diseases, Metabolic D001928 9 associated lipids
Leukocytosis D007964 9 associated lipids
Central Nervous System Diseases D002493 10 associated lipids
Brain Diseases, Metabolic, Inborn D020739 10 associated lipids
Abnormalities, Multiple D000015 13 associated lipids
Intellectual Disability D008607 13 associated lipids
Vomiting D014839 21 associated lipids
Per page 10 20 | Total 14

PubChem Associated disorders and diseases

What pathways are associated with Ethylmalonic acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Ethylmalonic acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Ethylmalonic acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Ethylmalonic acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Ethylmalonic acid?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Ethylmalonic acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Ethylmalonic acid?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Ethylmalonic acid

Download all related citations
Per page 10 20 50 100 | Total 119
Authors Title Published Journal PubMed Link
Pedersen CB et al. The ACADS gene variation spectrum in 114 patients with short-chain acyl-CoA dehydrogenase (SCAD) deficiency is dominated by missense variations leading to protein misfolding at the cellular level. 2008 Hum. Genet. pmid:18523805
Gregersen N et al. Identification of four new mutations in the short-chain acyl-CoA dehydrogenase (SCAD) gene in two patients: one of the variant alleles, 511C-->T, is present at an unexpectedly high frequency in the general population, as was the case for 625G-->A, together conferring susceptibility to ethylmalonic aciduria. 1998 Hum. Mol. Genet. pmid:9499414
Kristensen MJ et al. Amino acid polymorphism (Gly209Ser) in the ACADS gene. 1994 Hum. Mol. Genet. pmid:7833941
Ballard CG et al. Eating disorder in a 6-year-old Asian girl with ethyl malonic adipic aciduria. 1993 Int J Eat Disord pmid:8477295
Eastman MA et al. Conformation of the 18-23 loop region of bovine prothrombin in the absence and presence of a model Ca2+ ion. An energy minimization study. 1986 Int. J. Pept. Protein Res. pmid:3733321
Linster CL et al. Ethylmalonyl-CoA decarboxylase, a new enzyme involved in metabolite proofreading. 2011 J. Biol. Chem. pmid:22016388
Das AM et al. Inborn errors of energy metabolism associated with myopathies. 2010 J. Biomed. Biotechnol. pmid:20589068
Okuyaz C et al. Severe infantile hypotonia with ethylmalonic aciduria: case report. 2008 J. Child Neurol. pmid:18539996
Pavlou E et al. An infant with ethylmalonic encephalopathy masquerading as a hematologic disorder. 2013 J. Child Neurol. pmid:22805253
Amendt BA et al. Short-chain acyl-coenzyme A dehydrogenase deficiency. Clinical and biochemical studies in two patients. 1987 J. Clin. Invest. pmid:3571488
Amendt BA and Rhead WJ The multiple acyl-coenzyme A dehydrogenation disorders, glutaric aciduria type II and ethylmalonic-adipic aciduria. Mitochondrial fatty acid oxidation, acyl-coenzyme A dehydrogenase, and electron transfer flavoprotein activities in fibroblasts. 1986 J. Clin. Invest. pmid:3722376
Ikeda Y et al. Biosynthesis of electron transfer flavoprotein in a cell-free system and in cultured human fibroblasts. Defect in the alpha subunit synthesis is a primary lesion in glutaric aciduria type II. 1986 J. Clin. Invest. pmid:3760196
Elias E et al. Ethylmalonic adipic aciduria--a treatable hepatomuscular disorder in two adult brothers. 1997 J. Hepatol. pmid:9059968
Bross P et al. Single-nucleotide variations in the genes encoding the mitochondrial Hsp60/Hsp10 chaperone system and their disease-causing potential. 2007 J. Hum. Genet. pmid:17072495
Lehnert W and Ruitenbeek W Ethylmalonic aciduria associated with progressive neurological disease and partial cytochrome c oxidase deficiency. 1993 J. Inherit. Metab. Dis. pmid:7609451
Garavaglia B et al. Muscle cytochrome c oxidase deficiency in two Italian patients with ethylmalonic aciduria and peculiar clinical phenotype. 1994 J. Inherit. Metab. Dis. pmid:7807937
Yoon HR et al. Therapeutic trial in the first three Asian cases of ethylmalonic encephalopathy: response to riboflavin. 2001 J. Inherit. Metab. Dis. pmid:11916321
Schmidt SP et al. Toxic response caused by a misfolding variant of the mitochondrial protein short-chain acyl-CoA dehydrogenase. 2011 J. Inherit. Metab. Dis. pmid:21170680
Seidel J et al. Recurrent vomiting and ethylmalonic aciduria associated with rare mutations of the short-chain acyl-CoA dehydrogenase gene. 2003 J. Inherit. Metab. Dis. pmid:12872838
Fu X et al. Mutation analysis of copper transporter genes in patients with ethylmalonic encephalopathy, mitochondriopathies and copper deficiency phenotypes. 2003 J. Inherit. Metab. Dis. pmid:12872841
Barth M et al. Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy. 2010 J. Inherit. Metab. Dis. pmid:20978941
Pedersen CB et al. Antioxidant dysfunction: potential risk for neurotoxicity in ethylmalonic aciduria. 2010 J. Inherit. Metab. Dis. pmid:20443061
Merinero B et al. Persistent increase of plasma butyryl/isobutyrylcarnitine concentrations as marker of SCAD defect and ethylmalonic encephalopathy. 2006 J. Inherit. Metab. Dis. pmid:16906473
Read MH et al. Clinical, biochemical, magnetic resonance imaging (MRI) and proton magnetic resonance spectroscopy (1H MRS) findings in a fourth case of combined D- and L-2 hydroxyglutaric aciduria. 2005 J. Inherit. Metab. Dis. pmid:16435212
van Maldegem BT et al. Clinical aspects of short-chain acyl-CoA dehydrogenase deficiency. 2010 J. Inherit. Metab. Dis. pmid:20429031
Rodenburg RJ Biochemical diagnosis of mitochondrial disorders. 2011 J. Inherit. Metab. Dis. pmid:20440652
Bosch AM et al. Brown-Vialetto-Van Laere and Fazio Londe syndrome is associated with a riboflavin transporter defect mimicking mild MADD: a new inborn error of metabolism with potential treatment. 2011 J. Inherit. Metab. Dis. pmid:21110228
Hoffmann GF et al. Progressive fatal pancytopenia, psychomotor retardation and muscle carnitine deficiency in a child with ethylmalonic aciduria and ethylmalonic acidaemia. 1990 J. Inherit. Metab. Dis. pmid:2172644
Sack I and Vega S Efficient deuterium-carbon REDOR NMR spectroscopy. 2000 J. Magn. Reson. pmid:10873496
Tiranti V et al. ETHE1 mutations are specific to ethylmalonic encephalopathy. 2006 J. Med. Genet. pmid:16183799
Grosso S et al. Ethylmalonic encephalopathy: further clinical and neuroradiological characterization. 2002 J. Neurol. pmid:12382164
Burlina AB et al. A new syndrome with ethylmalonic aciduria and normal fatty acid oxidation in fibroblasts. 1994 J. Pediatr. pmid:8283379
Harpey JP et al. Sudden infant death syndrome and multiple acyl-coenzyme A dehydrogenase deficiency, ethylmalonic-adipic aciduria, or systemic carnitine deficiency. 1987 J. Pediatr. pmid:3585604
van Maldegem BT et al. Clinical, biochemical, and genetic heterogeneity in short-chain acyl-coenzyme A dehydrogenase deficiency. 2006 JAMA pmid:16926354
Chae JH et al. Risk factors of ocular involvement in children with mitochondrial respiratory chain complex defect. 2010 Korean J Pediatr pmid:21253313
Burlina A et al. New clinical phenotype of branched-chain acyl-CoA oxidation defect. 1991 Lancet pmid:1683940
Barschak AG et al. Inhibition of the electron transport chain and creatine kinase activity by ethylmalonic acid in human skeletal muscle. 2006 Metab Brain Dis pmid:16773466
Ferreira Gda C et al. Effect of in vivo administration of ethylmalonic acid on energy metabolism in rat tissues. 2006 Metab Brain Dis pmid:16773468
Dweikat I et al. Ethylmalonic encephalopathy associated with crescentic glomerulonephritis. 2012 Metab Brain Dis pmid:22584649
Nowaczyk MJ et al. Ethylmalonic and methylsuccinic aciduria in ethylmalonic encephalopathy arise from abnormal isoleucine metabolism. 1998 Metab. Clin. Exp. pmid:9667231
Amaral AU et al. Ethylmalonic acid impairs brain mitochondrial succinate and malate transport. 2012 Mol. Genet. Metab. pmid:22133302
Westermann CM et al. Decreased oxidative phosphorylation and PGAM deficiency in horses suffering from atypical myopathy associated with acquired MADD. 2011 Mol. Genet. Metab. pmid:21843962
Di Rocco M et al. A case of ethylmalonic encephalopathy with atypical clinical and biochemical presentation. 2006 Mol. Genet. Metab. pmid:16828325
Gallant NM et al. Biochemical, molecular, and clinical characteristics of children with short chain acyl-CoA dehydrogenase deficiency detected by newborn screening in California. 2012 Mol. Genet. Metab. pmid:22424739
Dusheiko G et al. Recurrent hypoglycemia associated with glutaric aciduria type II in an adult. 1979 N. Engl. J. Med. pmid:514320
Tiranti V et al. Loss of ETHE1, a mitochondrial dioxygenase, causes fatal sulfide toxicity in ethylmalonic encephalopathy. 2009 Nat. Med. pmid:19136963
Viscomi C et al. Combined treatment with oral metronidazole and N-acetylcysteine is effective in ethylmalonic encephalopathy. 2010 Nat. Med. pmid:20657580
Srb V et al. Cytogenetic monitoring of a 24-hour effect of ethylmalonate platinum complex on human peripheral blood lymphocytes. 1986 Neoplasma pmid:3785467
Leipnitz G et al. Ethylmalonic acid inhibits mitochondrial creatine kinase activity from cerebral cortex of young rats in vitro. 2003 Neurochem. Res. pmid:12716029
Schuck PF et al. Promotion of lipid and protein oxidative damage in rat brain by ethylmalonic acid. 2010 Neurochem. Res. pmid:19757035